Navigation Links
Garland Andres, NP-C, Receives InTone Specialist Certification To Treat Female Urinary Incontinence From InControl Medical, LLC
Date:3/23/2013

Atlanta, GA (PRWEB) March 23, 2013

InTone, developed by InControl Medical, LLC, is a medical device available by prescription, indicated for the treatment of stress incontinence, urge incontinence or mixed (stress and urge) incontinence. Available by prescription, InTone combines a daily program of volitional exercises, voice-guided instruction, biofeedback and micro-current stimulation to strengthen muscle tone in the pelvic floor.

Stress incontinence can occur when lifting, sneezing, coughing, laughing or exercising. Urge incontinence is the unwanted and sudden need to urinate. Both can be caused or exacerbated by childbirth, obesity, excessive exercise, lack of exercise, age or trauma.

According to the National Association for Continence, up to 30 million women in America have experienced bladder leakage issues. About one in four new mothers experience “leaking” following normal delivery, and about one in six following cesarean section.

Up to two-thirds of women who “leak” have never mentioned it to their physicians, and up to two-thirds of women do not use any treatment or product to manage their bladder leakage.

Until now, available options had mixed results. Absorbent pads and diapers do nothing to treat the condition. Medications, if prescribed, can cause side effects and are not always effective. Surgery, if performed, is a more invasive option, and is not always effective. Research has shown that even when properly taught how to perform pelvic floor, or Kegel, exercises, about half of all women do them incorrectly.

When asked about treating incontinence Garland Andres, NP-C, stated “I'm excited to offer a nonsurgical option for the treatment of incontinence. I think it will be of great benefit for my patients."

After prescribing InTone, the physician customizes the settings for InTone and the patient is shown how to use it at home. A sensor in the unit measures pressure to determine if the patient is doing the exercises properly. The biofeedback unit uses voice-guided instruction to take her through the routine and reports her muscle isolation and strength. Each daily session takes about ten minutes, and data from each session is recorded. After two weeks or so, the physician analyzes the recorded data and adjusts InTone based on the patient’s progress, and at-home treatment sessions continue. Most patients should experience progress in a few weeks, and most patients should experience effective relief in 90 days.

InTone is available by prescription to patients in the United States. InTone was developed by InControl Medical, LLC, based in Brookfield, Wisconsin. InControl Medical provides specialty medical products for women’s health, and is sourced and manufactured entirely in the United States. More information on InTone can be found at http://www.incontrolmedical.com.

To contact Garland Andres, NP-C, please call (404) 255-3633 or go to the Northside Northpoint OB-GYN website, http://www.nsnpobgyn.com.

Read the full story at http://www.prweb.com/releases/2013/3/prweb10561034.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Garland Canada Introduces White-Stallion® All-Purpose Primer for Metal Roofs
2. Loyola Cancer Center receives Outstanding Achievement Award
3. MU receives national award for using mind-body approach to improve health
4. Neuropsychologist receives University of Houstons highest faculty honor
5. Boston researcher, surgical oncologist receives national award
6. LA BioMed receives Grand Challenges Explorations grant
7. Lawson researcher receives 1 of first-ever Pfizer Psychiatry Research Awards
8. Dr. Arthur Slutsky, vice-president of research at St. Michaels, receives lifetime award
9. UC San Diego Superfund Research Program receives $15 million grant renewal
10. Markey receives $6.25 million to study deadly blood and bone marrow disease
11. Feola, at University of Kentucky, receives NIH grant to study cystic fibrosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... Doctor C ... it attended the January ECRM trade show to continue the marketing and distribution of ... C supplement, known for providing 400 percent better absorption than traditional vitamin C supplements. ...
(Date:1/20/2017)... ... January 20, 2017 , ... International Protein, a company based out of ... it attended the January ECRM trade show in Hilton Head, SC. , International ... determined to create a line of products that would elevate her fitness regime. At ...
(Date:1/20/2017)... ... ... “Mary Magdalene: Grace is Greater than Sin”: a unique and memorable piece of ... Magdalene: Grace is Greater than Sin” is the creation of published author, Brenda Roberts, ... who had little knowledge of the female characters portrayed in the Holy Bible. ...
(Date:1/20/2017)... Farmville, NC (PRWEB) , ... January 20, 2017 ... ... the vPEP ® Oscillating Positive Expiratory Pressure (OPEP) device, was featured in ... article by Doug Pursley, MEd, RRT-ACCS, FAARC, “Analysis of Three Oscillating Positive ...
(Date:1/20/2017)... ... ... “The Land of More and More”: a brilliant story for children ... the simple and achievable answer. “The Land of More and More” is the creation ... in Angola, Indiana where he works with the children’s ministry department. , Michael ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 19, 2017 Incretin Mimetics/GLP-1 Agonists, SNDRIs, Lipase ... The global anti-obesity drugs market is expected to ... the forecast period and CAGR of 38.7% in the second half ... a CAGR of 32.8% from 2016 to 2027. The market is ... $24,063 million in 2027. ...
(Date:1/19/2017)... -- Accuray Incorporated (Nasdaq: ARAY ) announced ... set the bar for excellence in customer satisfaction. The ... rating among radiation treatment delivery systems in the U.S., ... Briefing™. The most recent ratings trend also shows Accuray ... for 11 of the past 12 quarters. ...
(Date:1/19/2017)... LONDON , January 19, 2017 ... Grothey ; European Oncology & Haematology, 2016;12(Suppl 2):3-8; ... ... http://photos.prnewswire.com/prnh/20151014/276718LOGO) Published recently in ... the peer-reviewed journal from touchONCOLOGY, an article by ...
Breaking Medicine Technology: